Upstream Bio (UPB) Common Equity (2023 - 2025)
Historic Common Equity for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $378.6 million.
- Upstream Bio's Common Equity rose 33615.6% to $378.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $378.6 million, marking a year-over-year increase of 33615.6%. This contributed to the annual value of $469.9 million for FY2024, which is 48160.26% up from last year.
- As of Q3 2025, Upstream Bio's Common Equity stood at $378.6 million, which was up 33615.6% from $408.7 million recorded in Q2 2025.
- Over the past 5 years, Upstream Bio's Common Equity peaked at $469.9 million during Q4 2024, and registered a low of -$160.3 million during Q3 2024.
- For the 3-year period, Upstream Bio's Common Equity averaged around $114.1 million, with its median value being -$112.2 million (2023).
- Data for Upstream Bio's Common Equity shows a peak YoY increase of 48160.26% (in 2024) and a maximum YoY decrease of 4287.46% (in 2024) over the last 5 years.
- Quarter analysis of 3 years shows Upstream Bio's Common Equity stood at -$123.1 million in 2023, then surged by 481.6% to $469.9 million in 2024, then decreased by 19.42% to $378.6 million in 2025.
- Its last three reported values are $378.6 million in Q3 2025, $408.7 million for Q2 2025, and $445.6 million during Q1 2025.